Search

Start Over Keyword ADVERSE PATHOLOGY

  • Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality

    Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality
    Authors:Kathryn L. Pellegrini, Emory UniversityMartin Sanda, Emory UniversityDattatraya Patil, Emory UniversityQi Long, Emory UniversityMaria Santiago-Jimenez, GenomeDx BiosciencesMandeep Takhar, GenomeDx BiosciencesNicholas Erho, GenomeDx BiosciencesKasra Yousefi, GenomeDx BiosciencesElai Davicioni, GenomeDx BiosciencesEric A. Klein, Cleveland ClinicRobert B. Jenkins, Mayo ClinicR. Jeffery Karnes, Mayo ClinicCarlos S Moreno, Emory University
    Date:2017
    Publisher:Wiley: 12 months
    Publication Version:Author Accepted Manuscript (After Peer Review)